Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

Planning for the Ideal Cath Lab Requires the Multidisciplinary Approach

Planning and creating the best cath lab for your facility and market requires a wide range of considerations, from current and future business patterns to space design to workflow and communication concerns. A good plan that includes input from all the relevant stakeholders goes a long way toward a successful long-term venture.

Roundtable Discussion: The Big 4 Stentmakers

Cardiovascular Business invited representatives from the four major stent manufacturers to discuss the challenges and future outlook for drug-eluting stents (DES).

Overcoming Barriers to Cath Lab Inventory Control

As multifunctional cardiac catheterization labs see new cardiovascular products constantly arriving and old ones getting pushed to the back shelves, administrators need a well-organized storage space, as well as a sophisticated method for integrated inventory management to control costs and revenue.

Can Off-Hour D2B Times be Reduced Without Breaking the Bank

The persistent discrepancy between the door-to-balloon times of on-hours versus off-hours in STEMI patients undergoing PCI procedures can be solved through cost-effective means; however, some argue that an expensive and complex pre-activation program is needed to bring off-hour times in line with those of on-hours.

Cath Lab Exposé: What it takes to keep patients, profits, and referring docs in today's changing landscape

Cardiac cath labs operate in an increasingly challenging environment, contending with a variety of clinical, demographic, regulatory and competitive factors.

Wracked by Bad Press, Drug-Eluting Stents Start Their Comeback

The utilization of drug-eluting stents may be poised for a comeback based on recent clinical studies that found they have value despite some risks. Industry analysts, however, suggest that there their usage has plateaued and they can not maintain their initial groundbreaking sales. 

Coronary Intervention: Financial Factors Facing Cath Labs

Recent trial results, multidetector CT and new and more uses for the services and equipment of the traditional cardiac catheterization lab are impacting the bottom line of facilities across the country. These and more factors may have temporarily decreased cath lab procedures, but experts in the field predict recovery—albeit a changing face for the cath lab.

Strategies to Trim Door-to-Balloon Time

Door-to-balloon time (D2B) is a critical cardiac quality indicator. As a whole, U.S. hospitals are doing fairly well with other quality indicators, says Betsy Bradley, PhD, professor of public health at Yale University in New Haven, Conn., but D2B time is a challenge for many sites. Here are some prescriptions to break the 90-minute barrier.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.